Portfolio (Quarterly)
Guide ↗
BIOS Capital Management, LP
· CIK 0001813845| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACTU | ACTUATE THERAPEUTICS INC | Healthcare | 10,049,996.0 | $61.5M | 74.44% | — | — | $6.12 | -57.2% |
| 2 | CGTX | COGNITION THERAPEUTICS INC | Healthcare | 6,000,000.0 | $8.1M | 9.80% | — | — | $1.35 | -15.6% |
| 3 | — | OPUS GENETICS INC | — | 3,683,429.0 | $7.4M | 8.96% | — | — | $2.01 | — |
| 4 | LTRN | LANTERN PHARMA INC | Healthcare | 1,009,507.0 | $3.1M | 3.70% | -6K | -0.6% | $3.03 | +3.6% |
| 5 | RNTX | REIN THERAPEUTICS INC | Healthcare | 1,690,751.0 | $2.0M | 2.37% | — | — | $1.16 | -9.5% |
| 6 | INAB | IN8BIO INC | Healthcare | 253,417.0 | $593K | 0.72% | NEW | — | $2.34 | -36.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%